Background CSF and PET biomarkers of amyloid β and tau accurately detect Alzheimer's
disease pathology, but the invasiveness, high cost, and poor availability of these detection …

Compelling experimental evidence suggests that microglial activation is involved in the spread
of tau tangles over the neocortex in Alzheimer’s disease (AD). We tested the hypothesis …

Importance Glial fibrillary acidic protein (GFAP) is a marker of reactive astrogliosis that
increases in the cerebrospinal fluid (CSF) and blood of individuals with Alzheimer disease (AD). …

Gold-standard diagnosis of Alzheimer’s disease (AD) relies on histopathological staging
systems. Using the topographical information from [ 18 F]MK6240 tau positron-emission …

Braak stages of tau neurofibrillary tangle accumulation have been incorporated in the
criteria for the neuropathological diagnosis of Alzheimer’s disease. It is expected that Braak …

Importance Apolipoprotein E ε4 (APOEε4) is the single most important genetic risk factor for
Alzheimer disease. WhileAPOEε4is associated with increased amyloid-β burden, its …

Animal studies suggest that the apolipoprotein E ε4 (APOEε4) allele is a culprit of early
microglial activation in Alzheimer’s disease (AD). Here, we tested the association between …

Background Imaging agents capable of quantifying the brain’s tau aggregates will allow a
more precise staging of Alzheimer’s disease (AD). The aim of the present study was to …

Tracking longitudinal tau tangles accumulation across the Alzheimer’s disease continuum is
crucial to better understand the natural history of tau pathology and for clinical trials. …

Introduction Mild behavioral impairment (MBI) is characterized by the emergence of
neuropsychiatric symptoms in elderly persons. Here, we examine the associations between MBI and …